Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Juanbi Qianggu Formula (蠲痹強骨方) is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine. It is specifically formulated to treat musculoskeletal and inflammatory joint conditions, such as knee osteoarthritis and rheumatoid arthritis, particularly in patients presenting with the TCM syndrome of liver and kidney deficiency. The formula is designed to alleviate pain, reduce inflammation, and strengthen bone and cartilage structure. It has been evaluated in clinical trials as both a monotherapy and as an adjunct to conventional treatments like methotrexate and celecoxib.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Juanbi Qianggu Formula.